AAAAAA

   
Results: 1-8 |
Results: 8

Authors: WELL M NABER KG KINZIGSCHIPPERS M SORGEL F
Citation: M. Well et al., URINARY BACTERICIDAL ACTIVITY AND PHARMACOKINETICS OF ENOXACIN VERSUSNORFLOXACIN AND CIPROFLOXACIN IN HEALTHY-VOLUNTEERS AFTER A SINGLE ORAL DOSE, International journal of antimicrobial agents, 10(1), 1998, pp. 31-38

Authors: KINZIGSCHIPPERS M FUHR U CESANA M MULLER C STAIB AH RIETBROCK S SORGEL F
Citation: M. Kinzigschippers et al., ABSENCE OF EFFECT OF RUFLOXACIN ON THEOPHYLLINE PHARMACOKINETICS IN STEADY-STATE, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2359-2364

Authors: NAU R LASSEK C KINZIGSCHIPPERS M THIEL A PRANGE HW SORGEL F
Citation: R. Nau et al., DISPOSITION AND ELIMINATION OF MEROPENEM IN CEREBROSPINAL-FLUID OF HYDROCEPHALIC PATIENTS WITH EXTERNAL VENTRICULOSTOMY, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 2012-2016

Authors: NABER KG WELL M KINZIGSCHIPPERS M SORGEL F
Citation: Kg. Naber et al., URINARY BACTERICIDAL ACTIVITY AND CONCENTRATIONS OF ENOXACIN VERSUS NORFLOXACIN AND CIPROFLOXACIN IN HEALTHY-VOLUNTEERS AFTER A SINGLE ORALDOSE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4411-4411

Authors: ZLOTOS G BUCKER A KINZIGSCHIPPERS M SORGEL F HOLZGRABE U
Citation: G. Zlotos et al., PLASMA-PROTEIN BINDING OF GYRASE INHIBITORS, Journal of pharmaceutical sciences, 87(2), 1998, pp. 215-220

Authors: HOFBAUER H NABER KG KINZIGSCHIPPERS M SORGEL F RUSTIGEWIEDEMANN C WIEDEMANN B REIZ A KRESKEN M
Citation: H. Hofbauer et al., URINE BACTERICIDAL ACTIVITY OF PEFLOXACIN VERSUS NORFLOXACIN IN HEALTHY FEMALE VOLUNTEERS AFTER A SINGLE 800-MG ORAL DOSE, Infection, 25(2), 1997, pp. 121-126

Authors: NAU R KINZIGSCHIPPERS M SORGEL F SCHINSCHKE S ROSSING R MULLER C KOLENDA H PRANGE HW
Citation: R. Nau et al., KINETICS OF PIPERACILLIN AND TAZOBACTAM IN VENTRICULAR CEREBROSPINAL-FLUID OF HYDROCEPHALIC PATIENTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 987-991

Authors: SORGEL F ZAIGLER M MEDERT G KINZIGSCHIPPERS M KOHLER H PATZELTBATH A RUSING G FUHR U STAIB AH
Citation: F. Sorgel et al., GLIBENCLAMIDE - AN EXAMPLE HOW APPARENT ELIMINATION HALF-LIFE AND BIOAVAILABILITY MAY DEPEND ON ASSAY SENSITIVITY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 486-486
Risultati: 1-8 |